3659 On Other Exchanges
Symbol
Exchange
3659 is not on other exchanges.

Executive Profile*

Shiro Kuniya

External Director,NEXON Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 48 board members in 4 different organizations across 6 different industries.

See Board Relationships
60--

Background*

Mr. Shiro Kuniya serves as the Managing Partner of Oh-Ebashi LPC & Partners and served as its Senior Partner since April 2002. Mr. Kuniya has been Auditor-Secretary, Koeki Zaidan Hojin Tazuke Okikaze Kai Kitano Hospital since June 1999. He joined Oh-Ebashi Law Office in April 1982. He has been an Outside Independent Director at Ebara Corp., since June 2012. He has been an Outside Independent Director at Sony Financial Holdings Inc., since June 2013. He has been External ...

Read Full Background

Corporate Headquarters*

2-3-1 Shinkawa
Tokyo, -- 104-0033

Japan

Phone: 81 3 3523 7911
Fax: --

Board Members Memberships*

2012-Present
Outside Independent Director
2012-Present
External Director
2013-Present
Outside Independent Director
2016-Present
External Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michel Vounatsos CEO & Director
Biogen Inc.
$2.0M
Vincent A. Forlenza Chairman and Chief Executive Officer
Becton, Dickinson and Company
$1.1M
Lars Fruergaard Jørgensen President & CEO
Novo Nordisk A/S
kr8.7M
Hervé Hoppenot Chairman of the Board, Chief Executive Officer and President
Incyte Corporation
$937.7K
Joseph C. Papa Chairman & CEO
Valeant Pharmaceuticals International, Inc.
$10.1M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NEXON CO LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.